Nephros (NEPH) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Nephros (NEPH) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.87% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -74.21% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 0.63% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -33.92% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67.34% |
| Mar 31, 2026 | 36.31% |
| Sep 30, 2025 | 36.52% |
| Jun 30, 2025 | 26.65% |
| Mar 31, 2025 | 26.73% |
| Dec 31, 2024 | 52.29% |
| Sep 30, 2024 | 37.98% |
| Jun 30, 2024 | 64.47% |
| Mar 31, 2024 | 57.38% |
| Dec 31, 2023 | 26.90% |
| Sep 30, 2023 | 79.76% |
| Jun 30, 2023 | 62.71% |
| Mar 31, 2023 | 35.10% |
| Dec 31, 2022 | -7.99% |
| Sep 30, 2022 | -11.40% |
| Jun 30, 2022 | -30.04% |
| Mar 31, 2022 | -12.71% |
| Dec 31, 2021 | -29.12% |
| Sep 30, 2021 | 15.42% |
| Jun 30, 2021 | -79.83% |